Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vertex Pharmaceutic 50 NORTHERN AVENUE BOSTON MA 02210 USA

P: 617-341-6100

Description:

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

Key Statistics

Overview:

Market Capitalization, $K 56,323,600
Shares Outstanding, K 259,269
Annual Sales, $ 4,163 M
Annual Net Income, $ 1,177 M
Last Quarter Sales, $ 1,413 M
Last Quarter Net Income, $ 583,230 K
60-Month Beta 1.32
% of Insider Shareholders 0.70%
% of Institutional Shareholders 94.00%
Float, K 257,454
% Float 99.30%

Growth:

1-Year Return 16.91%
3-Year Return 98.66%
5-Year Return 85.31%
5-Year Revenue Growth 617.21%
5-Year Earnings Growth 246.42%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.70 on 01/30/20
Next Earnings Date 05/05/20
Earnings Per Share ttm 4.25
EPS Growth vs. Prev Qtr 48.45%
EPS Growth vs. Prev Year 44.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 2-1 on 08/24/00

VRTX Ratios

Ratio
Price/Earnings ttm 52.82
Price/Earnings forward 77.38
Price/Earnings to Growth 1.23
Return-on-Equity % 20.97%
Return-on-Assets % 15.07%
Profit Margin % 28.27
Net Margin % -266.58
Debt/Equity 0.12
Price/Sales 13.98
Price/Cash Flow 47.10
Price/Book 9.49
Book Value/Share 23.66
Interest Coverage 24.84
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar